Apr 08, 2020
Lannett To Meet With FDA Regarding The Clinical Advancement Of Biosimilar Insulin Glargine On June 9
Apr 07, 2020
Oramed Patent in Canada Allowed for Oral Delivery of Proteins
Apr 07, 2020
New $35 Co-Pay Now Available Through Lilly Insulin Value Program in Response to COVID-19 Crisis in U.S.
Apr 02, 2020
Insulin Patch Pumps Market Size Worth $1.7 Billion by 2027 | CAGR: 10.9%: Grand View Research, Inc.
Apr 01, 2020
Oramed Pharmaceuticals Issues CEO Shareholder Letter Providing Business Update Amid COVID-19
Mar 24, 2020
Updates from Lilly about insulin supply and affordability
Mar 23, 2020
2020 Pipeline Insight on Insulin Resistance
Mar 19, 2020
Oramed Receives Positive Feedback From End-of-Phase 2 Oral Insulin CMC Meeting With FDA
Feb 27, 2020
North America Diabetes Care Devices Market - Growth, Trends, and Forecast (2020 - 2025)
Feb 20, 2020
Companion Medical's InPen Diabetes Management System Receives FDA Clearance for use with Fiasp® Insulin
Feb 19, 2020
DarioHealth® Presents New Clinical Study Outcomes Showing the Dario Digital Therapeutics Platform Helps Insulin Dependent Patients With Diabetes Better Manage Their Chronic Condition
Feb 14, 2020
European Biosimilar Insulin Glargine & Lispro Market Analysis, 2014-2024 - Growing Concerns Regarding the Cost of Insulin Treatment Spurs Demand
Feb 13, 2020
The Difficulty of Defeating Obesity is the Basis of Bariatric Medicine, says West Medical
Feb 11, 2020
Biotech Brief: Global Diabetes Drug Market Could Reach $78 Billion By End Of 2026
Feb 07, 2020
Global Insulin Drugs Industry Forecasts 2020-2030 - Novo Nordisk's 2020 Diabetes Pill Expected to Generate About $5 Billion in Annual Sales
Jan 28, 2020
Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
Jan 28, 2020
Oramed Patent in Europe to be Granted for Oral Delivery of Proteins
Jan 28, 2020
Non-Injectable Insulin Markets, 2018-2019 & 2024 - Market Trends & Size, Key Areas for Growth & Adoption, Major Player Profiles
Jan 27, 2020
The European human insulin market is expected to register a CAGR of 4.3% during the forecast period (2019-2024
Jan 23, 2020
Oramed Elects Dr. Alexander Fleming to Scientific Advisory Board